Exchange Rates 2007

Return to Exchange Rates

Table of Contents

1. December 2007
2. November 2007
3. October 2007
4. September 2007
5. August 2007
6. July 2007
7. June 2007
8. May 2007
9. April 2007
10. March 2007
11. February 2007
12. January 2007

December 2007

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2007 will be used in the review of prices for existing medicines in the second half of 2007.

The international prices of an existing drug product for the period January to December 2007 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2007

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between June 2007 to May 2008

For more information call our toll-free number 1 877 861-2350

November 2007

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2007 will be used in the review of prices for existing medicines in the first half of 2007.

The international prices of an existing drug product for the period January to June 2007 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending June 2007

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between May 2007 to April 2008

For more information call our toll-free number 1 877 861-2350

October 2007

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2007 will be used in the review of prices for existing medicines in the first half of 2007.

The international prices of an existing drug product for the period January to June 2007 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending June 2007

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between April 2007 to March 2008

For more information call our toll-free number 1 877 861-2350

September 2007

The methodology for calculating exchange rates for purposes of the PMPRB's International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2007 will be used in the review of prices for existing medicines in the first half of 2007.

The international prices of an existing drug product for the period January to June 2007 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending June 2007

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between March 2007 to February 2008

For more information call our toll-free number 1 877 861-2350

August 2007

The methodology for calculating exchange rates for purposes of the PMPRB's International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2007 will be used in the review of prices for existing medicines in the first half of 2007.

The international prices of an existing drug product for the period January to June 2007 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending June 2007

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between February 2007 to January 2008

For more information call our toll-free number 1 877 861-2350

July 2007

The methodology for calculating exchange rates for purposes of the PMPRB's International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2007 will be used in the review of prices for existing medicines in the first half of 2007.

The international prices of an existing drug product for the period January to June 2007 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending June 2007

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between January 2007 to November 2007

For more information call our toll-free number 1 877 861-2350

June 2007

The methodology for calculating exchange rates for purposes of the PMPRB's International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2007 will be used in the review of prices for existing medicines in the first half of 2007.

The international prices of an existing drug product for the period January to June 2007 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending June 2007

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between December 2006 to November 2007

For more information call our toll-free number 1 877 861-2350

May 2007

The methodology for calculating exchange rates for purposes of the PMPRB's International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2006 will be used in the review of prices for existing medicines in the second half of 2006.

The international prices of an existing drug product for the period January to December 2006 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2006

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in April 2007, the exchange rates used are April 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between November 2006 to October 2007

For more information call our toll-free number 1 877 861-2350

April 2007

The methodology for calculating exchange rates for purposes of the PMPRB's International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2006 will be used in the review of prices for existing medicines in the second half of 2006.

The international prices of an existing drug product for the period January to December 2006 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2006

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in April 2007, the exchange rates used are April 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between October 2006 to September 2007

For more information call our toll-free number 1 877 861-2350

March 2007

The methodology for calculating exchange rates for purposes of the PMPRB's International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2006 will be used in the review of prices for existing medicines in the second half of 2006.

The international prices of an existing drug product for the period January to December 2006 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2006

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in April 2007, the exchange rates used are April 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between September 2006 to August 2007

For more information call our toll-free number 1 877 861-2350

February 2007

The methodology for calculating exchange rates for purposes of the PMPRB's International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2006 will be used in the review of prices for existing medicines in the second half of 2006.

The international prices of an existing drug product for the period January to December 2006 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2006

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in April 2007, the exchange rates used are April 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between August 2006 to July 2007

For more information call our toll-free number 1 877 861-2350

January 2007

The methodology for calculating exchange rates for purposes of the PMPRB's International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2006 will be used in the review of prices for existing medicines in the second half of 2006.

The international prices of an existing drug product for the period January to December 2006 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2006

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in April 2007, the exchange rates used are April 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced between July 2006 to June 2007

For more information call our toll-free number 1 877 861-2350